$LFVN
Lifevantage Corp

2020 Q2 Form 10-Q Financial Statement

#000084914620000082 Filed on May 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1 2019 Q1
Revenue $59.37M $56.08M $56.01M
YoY Change 5.69% 0.12% 10.78%
Cost Of Revenue $9.450M $9.095M $9.270M
YoY Change -2.68% -1.89% 3.91%
Gross Profit $49.92M $46.98M $46.74M
YoY Change 7.45% 0.51% 12.25%
Gross Profit Margin 84.08% 83.78% 83.45%
Selling, General & Admin $43.71M $17.28M $17.30M
YoY Change 7.16% -0.09% 15.13%
% of Gross Profit 87.56% 36.78% 37.0%
Research & Development $200.0K $100.0K
YoY Change 100.0% -66.67%
% of Gross Profit 0.43% 0.21%
Depreciation & Amortization $830.0K $700.0K $480.0K
YoY Change 53.7% 45.83% 77.78%
% of Gross Profit 1.66% 1.49% 1.03%
Operating Expenses $43.71M $43.95M $44.50M
YoY Change 7.16% -1.24% 13.11%
Operating Profit $6.209M $3.033M $2.241M
YoY Change 9.51% 35.34% -2.48%
Interest Expense $70.00K $30.00K $72.00K
YoY Change -119.44% -58.33% -21.74%
% of Operating Profit 1.13% 0.99% 3.21%
Other Income/Expense, Net -$190.0K -$367.0K -$83.00K
YoY Change -200.0% 342.17% 27.69%
Pretax Income $6.090M $2.666M $2.158M
YoY Change 10.73% 23.54% -3.36%
Income Tax $2.260M $1.005M $376.0K
% Of Pretax Income 37.11% 37.7% 17.42%
Net Earnings $3.824M $1.661M $1.782M
YoY Change -2.12% -6.79% 8.99%
Net Earnings / Revenue 6.44% 2.96% 3.18%
Basic Earnings Per Share $0.27 $0.12 $0.13
Diluted Earnings Per Share $0.26 $0.11 $0.12
COMMON SHARES
Basic Shares Outstanding 14.31M shares 14.25M shares 14.17M shares
Diluted Shares Outstanding 14.69M shares 15.29M shares

Balance Sheet

Concept 2020 Q2 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.14M $13.46M $15.91M
YoY Change 17.64% -15.4% 14.05%
Cash & Equivalents $22.14M $13.46M $15.91M
Short-Term Investments
Other Short-Term Assets $5.230M $6.080M $7.640M
YoY Change -28.45% -20.42% -2.68%
Inventory $13.89M $14.74M $14.49M
Prepaid Expenses
Receivables $2.610M $1.164M $1.916M
Other Receivables $0.00 $2.390M $2.710M
Total Short-Term Assets $43.87M $37.84M $42.68M
YoY Change 1.57% -11.35% 8.79%
LONG-TERM ASSETS
Property, Plant & Equipment $7.170M $7.384M $6.818M
YoY Change 0.55% 8.3% 20.46%
Goodwill
YoY Change
Intangibles $851.0K $884.0K $1.016M
YoY Change -13.43% -12.99% -11.5%
Long-Term Investments $2.210M $2.210M
YoY Change
Other Assets $1.663M $1.548M $1.245M
YoY Change 30.13% 24.34% -4.16%
Total Long-Term Assets $15.01M $14.50M $11.43M
YoY Change 24.2% 26.86% -2.32%
TOTAL ASSETS
Total Short-Term Assets $43.87M $37.84M $42.68M
Total Long-Term Assets $15.01M $14.50M $11.43M
Total Assets $58.88M $52.33M $54.11M
YoY Change 6.52% -3.28% 6.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.521M $4.004M $5.065M
YoY Change -32.03% -20.95% 9.42%
Accrued Expenses $10.31M $19.32M $20.29M
YoY Change -6.71% -4.78% 6.85%
Deferred Revenue $792.0K
YoY Change -20.64%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $1.939M
YoY Change -100.0% -100.0% -3.05%
Total Short-Term Liabilities $25.02M $23.32M $27.48M
YoY Change -4.49% -15.12% 6.96%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $604.0K $388.0K $1.881M
YoY Change -67.86% -79.37% -4.61%
Total Long-Term Liabilities $604.0K $388.0K $1.881M
YoY Change -67.86% -79.37% -68.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.02M $23.32M $27.48M
Total Long-Term Liabilities $604.0K $388.0K $1.881M
Total Liabilities $25.62M $23.74M $29.36M
YoY Change -8.73% -19.16% -7.17%
SHAREHOLDERS EQUITY
Retained Earnings -$93.31M -$97.13M -$100.9M
YoY Change -6.66% -3.75% -3.63%
Common Stock $126.4M $125.7M $125.7M
YoY Change -0.54% 0.0% 1.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $33.25M $28.60M $24.75M
YoY Change
Total Liabilities & Shareholders Equity $58.88M $52.33M $54.11M
YoY Change 6.52% -3.28% 6.24%

Cashflow Statement

Concept 2020 Q2 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $3.824M $1.661M $1.782M
YoY Change -2.12% -6.79% 8.99%
Depreciation, Depletion And Amortization $830.0K $700.0K $480.0K
YoY Change 53.7% 45.83% 77.78%
Cash From Operating Activities $9.350M $3.210M $3.870M
YoY Change 33.95% -17.05% 24.44%
INVESTING ACTIVITIES
Capital Expenditures -$570.0K -$480.0K -$1.420M
YoY Change -30.49% -66.2% 13.6%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$570.0K -$480.0K -$1.420M
YoY Change -30.49% -66.2% 13.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -150.0K -3.850M -5.490M
YoY Change -95.47% -29.87% 662.5%
NET CHANGE
Cash From Operating Activities 9.350M 3.210M 3.870M
Cash From Investing Activities -570.0K -480.0K -1.420M
Cash From Financing Activities -150.0K -3.850M -5.490M
Net Change In Cash 8.630M -1.120M -3.040M
YoY Change 202.81% -63.16% -366.67%
FREE CASH FLOW
Cash From Operating Activities $9.350M $3.210M $3.870M
Capital Expenditures -$570.0K -$480.0K -$1.420M
Free Cash Flow $9.920M $3.690M $5.290M
YoY Change 27.18% -30.25% 21.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000849146
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Document Period Start Date
DocumentPeriodStartDate
dei Entity File Number
EntityFileNumber
001-35647
dei Entity Registrant Name
EntityRegistrantName
LIFEVANTAGE CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0224471
dei Entity Address Address Line1
EntityAddressAddressLine1
9785 S. Monroe Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
dei Entity Address City Or Town
EntityAddressCityOrTown
Sandy
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84070
dei City Area Code
CityAreaCode
801
dei Local Phone Number
LocalPhoneNumber
432-9000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
dei Trading Symbol
TradingSymbol
LFVN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14313179 shares
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13464000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18824000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1164000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2066000 USD
CY2020Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2383000 USD
CY2019Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1236000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
14740000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
13753000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6084000 USD
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7309000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
37835000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
43188000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7384000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7131000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1536000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1536000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
884000 USD
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
983000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
941000 USD
CY2019Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2693000 USD
CY2020Q1 us-gaap Long Term Investments
LongTermInvestments
2205000 USD
CY2019Q1 us-gaap Long Term Investments
LongTermInvestments
0 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1548000 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1278000 USD
CY2020Q1 us-gaap Assets
Assets
52333000 USD
CY2019Q2 us-gaap Assets
Assets
55273000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4004000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5180000 USD
CY2020Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
8223000 USD
CY2019Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
7916000 USD
CY2020Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
0 USD
CY2019Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
592000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1843000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9254000 USD
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11053000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2019Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1454000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
23324000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
26195000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
388000 USD
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1879000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
23735000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
28074000 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14295000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14295000 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14114000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14114000 shares
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
125697000 USD
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
127096000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97132000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99960000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
32000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
62000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
28598000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
27199000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52333000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55273000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56077000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56012000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
173547000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
169788000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9095000 USD
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9270000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28515000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28263000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
46982000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
46742000 USD
us-gaap Gross Profit
GrossProfit
145032000 USD
us-gaap Gross Profit
GrossProfit
141525000 USD
CY2020Q1 lfvn Commission And Incentives
CommissionAndIncentives
26668000 USD
CY2019Q1 lfvn Commission And Incentives
CommissionAndIncentives
27205000 USD
lfvn Commission And Incentives
CommissionAndIncentives
82677000 USD
lfvn Commission And Incentives
CommissionAndIncentives
83166000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17281000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17296000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53098000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54213000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
43949000 USD
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
44501000 USD
us-gaap Operating Expenses
OperatingExpenses
135775000 USD
us-gaap Operating Expenses
OperatingExpenses
137379000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3033000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2241000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
9257000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4146000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
30000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
72000 USD
us-gaap Interest Expense
InterestExpense
119000 USD
us-gaap Interest Expense
InterestExpense
282000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-337000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-565000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-132000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-367000 USD
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-83000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-684000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-414000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2666000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2158000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8573000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3732000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1005000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
376000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
848000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
210000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1661000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1782000 USD
us-gaap Net Income Loss
NetIncomeLoss
7725000 USD
us-gaap Net Income Loss
NetIncomeLoss
3522000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14252000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14165000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14054000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14027000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14689000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15286000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14592000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14978000 shares
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-42000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-30000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-46000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-42000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-30000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-46000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1661000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1740000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7695000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3476000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
27199000 USD
CY2019Q3 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
508000 USD
CY2019Q3 lfvn Stockholders Equity Attributableto Parent Adjusted Balance
StockholdersEquityAttributabletoParentAdjustedBalance
27707000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1276000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11000 USD
CY2019Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
32000 shares
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
339000 USD
CY2019Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
61000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1393000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
1761000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
29624000 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1503000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54000 USD
CY2019Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4360000 USD
CY2019Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2012000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
4303000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
29098000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1191000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 USD
CY2020Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
31000 shares
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
314000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1674000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1661000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
28598000 USD
us-gaap Net Income Loss
NetIncomeLoss
7725000 USD
us-gaap Net Income Loss
NetIncomeLoss
3522000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1953000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1356000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4081000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4136000 USD
lfvn Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1731000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
7000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
39000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-144000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
23000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1587000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
906000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-887000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1147000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2267000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1151000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
878000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
992000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-692000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
279000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-7000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1154000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1266000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-592000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
149000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2008000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2161000 USD
lfvn Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-2004000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
294000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-416000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8977000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10805000 USD
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
0 USD
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
2000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2107000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1689000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2107000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3689000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5405000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1706000 USD
us-gaap Interest Paid Net
InterestPaidNet
43000 USD
us-gaap Interest Paid Net
InterestPaidNet
216000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1500000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3500000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6096000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3167000 USD
lfvn Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
653000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
74000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
565000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12274000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7808000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-47000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5360000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-739000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18824000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16652000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13464000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15913000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1377000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1195000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:8pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-indent:22.5pt;margin-top:8pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div>
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-500000 USD
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-44000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-500000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-100000 USD
CY2020Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
100000 USD
CY2019Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-100000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-200000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-200000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit RiskAccounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments.
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10330000 USD
CY2020Q1 lfvn Inventory Finished Goods Percent Of Total Inventory
InventoryFinishedGoodsPercentOfTotalInventory
0.701
CY2019Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9903000 USD
CY2019Q2 lfvn Inventory Finished Goods Percent Of Total Inventory
InventoryFinishedGoodsPercentOfTotalInventory
0.720
CY2020Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
4410000 USD
CY2020Q1 lfvn Raw Materials Percent Of Total Inventory
RawMaterialsPercentOfTotalInventory
0.299
CY2019Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
3850000 USD
CY2019Q2 lfvn Raw Materials Percent Of Total Inventory
RawMaterialsPercentOfTotalInventory
0.280
CY2020Q1 us-gaap Inventory Net
InventoryNet
14740000 USD
CY2020Q1 lfvn Inventory Percent Of Total Inventory
InventoryPercentOfTotalInventory
1.000
CY2019Q2 us-gaap Inventory Net
InventoryNet
13753000 USD
CY2019Q2 lfvn Inventory Percent Of Total Inventory
InventoryPercentOfTotalInventory
1.000
CY2020Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
200000 USD
CY2019Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
200000 USD
lfvn Money Back Guarantee Period
MoneyBackGuaranteePeriod
P30D
CY2020Q1 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
300000 USD
CY2019Q2 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
400000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200000 USD
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
800000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1000000.0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 USD
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000 shares
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1782000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1661000 USD
us-gaap Net Income Loss
NetIncomeLoss
7725000 USD
us-gaap Net Income Loss
NetIncomeLoss
3522000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14252000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14165000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14054000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14027000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
437000 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1121000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
538000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
951000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14689000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15286000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14592000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14978000 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
lfvn Number Of Geographic Segments
NumberOfGeographicSegments
2 Segment
lfvn Number Of Geographic Segments
NumberOfGeographicSegments
2 Segment
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56077000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56012000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
173547000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
169788000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3900000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3300000 USD
CY2020Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P1Y
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M10D
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0492
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
700000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
2000000.0 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
716000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2156000 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
707000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1192000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1899000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
33000 USD
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1866000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2872000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1140000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4012000 USD
CY2017Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000 USD
CY2017Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000 USD
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 USD
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
400000 shares
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5400000 USD
CY2020Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
3400000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1200000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
4000000.0 USD
CY2020Q1 lfvn Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities
SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities
-27000 USD
lfvn Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities
SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities
100000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1000000.0 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3600000 USD
CY2019Q1 lfvn Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities
SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities
100000 USD
lfvn Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities
SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities
500000 USD
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
Commitments and Contingencies<div style="margin-top:8pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Contingencies</span></div><div style="text-indent:22.5pt;margin-top:8pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accounts for contingent liabilities in accordance with ASC 450, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Contingencies</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, </span></div><div style="margin-top:8pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of March 31, 2020, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div><div style="margin-top:8pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Legal Accruals</span></div><div style="text-indent:22.5pt;margin-top:8pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div><div style="text-indent:22.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Class Action Lawsuit (</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Smith v. LifeVantage Corp</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">.): </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, Plaintiffs alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, Plaintiff's amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the Chief Executive Officer remains a defendant in the case). The Plaintiffs' amended complaint added an antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. The Company filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to the Company’s Motion to Dismiss on December 17, 2018, and the Company filed a reply brief on January 10, 2019. The Court ruled on the motion on December 5, 2019, dismissing three of the Plaintiff's four claims, including the antitrust claim, unjust enrichment claim, and the securities claim for the sale of unregistered securities. On December 19, 2019, Plaintiffs filed a second amended complaint which included three causes of action, including a 10(b)(5) securities fraud claim, and renewed claims relating to the sale of unregistered securities and unjust enrichment. The Company filed a Motion to Dismiss the Second Amended Complaint on January 28, 2020, and as of March 16, 2020, the Motion has been fully briefed for the court. The parties are now waiting for the court to schedule oral argument or the court may decide the matter on the papers. The Company has not established a loss contingency accrual for this lawsuit as it believes liability is not probable or estimable, and the Company plans to vigorously defend against this lawsuit. Nonetheless, an unfavorable resolution of this matter could have a material adverse effect on the Company's business, results of operations or financial condition.</span></div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Other Matters.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"> </span>In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.

Files In Submission

Name View Source Status
0000849146-20-000082-index-headers.html Edgar Link pending
0000849146-20-000082-index.html Edgar Link pending
0000849146-20-000082.txt Edgar Link pending
0000849146-20-000082-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lfvn-20200331.htm Edgar Link pending
lfvn-20200331.xsd Edgar Link pending
lfvn-20200331_cal.xml Edgar Link unprocessable
lfvn-20200331_def.xml Edgar Link unprocessable
lfvn-20200331_htm.xml Edgar Link completed
lfvn-20200331_lab.xml Edgar Link unprocessable
lfvn-20200331_pre.xml Edgar Link unprocessable
lfvn033120ex311.htm Edgar Link pending
lfvn033120ex312.htm Edgar Link pending
lfvn033120ex321.htm Edgar Link pending
lfvn033120ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending